Skip Navigation LinksHome > January 2013 - Volume 21 - Issue 1 > Successful Treatment of Osteomyelitis From Methicillin-Resis...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e31825b2110
Case Reports

Successful Treatment of Osteomyelitis From Methicillin-Resistant Staphylococcus Aureus With Ceftaroline

Watkins, Richard R. MD, MS, FACP

Collapse Box

Abstract

Abstract: Osteomyelitis due to methicillin-resistant Staphylococcus aureus (MRSA) is a challenging illness to treat because of limited antibiotic options. Ceftaroline is a novel cephalosporin with activity against MRSA. It is currently approved for the treatment of adults with community-acquired pneumonia (but not from MRSA) and bacterial skin and skin structure infections. This case report describes a patient with osteomyelitis from MRSA cured with ceftaroline.

© 2013 Lippincott Williams & Wilkins, Inc.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.